[Successful treatment of eruptive xanthomatosis with the antilipemic agents acipimox].
A 51-year-old male patient with histologically confirmed eruptive xanthomatosis is presented. Routine and special laboratory examinations showed complex disturbances of carbohydrate and lipid metabolism, the latter taking the form of classic hyperlipoproteinaemia type IV. Combined oral antilipaemic drugs including acipimox (methylpyrazine carboxylic acid analogue of nicotinic acid) and a low-fat diet resulted in regression of the skin symptoms and normalization of the serum lipid levels.
Zahorcsek
Z
Z
Dermatologische Klinik, Medizinischen Universität, Pécs.
Schneider
I
I
Hortobágyi
J
J
D003131:Combined Modality Therapy; D018752:Diet, Fat-Restricted; D006801:Humans; D006953:Hyperlipoproteinemia Type IV / Q000188:drug therapy* / Q000473:pathology; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011719:Pyrazines / Q000627:therapeutic use*; D012867:Skin / Q000473:pathology; D014973:Xanthomatosis / Q000188:drug therapy* / Q000473:pathology
D000960:Hypolipidemic Agents; D011719:Pyrazines; C027696:acipimox